IN2015CH01330A - - Google Patents

Download PDF

Info

Publication number
IN2015CH01330A
IN2015CH01330A IN1330CH2015A IN2015CH01330A IN 2015CH01330 A IN2015CH01330 A IN 2015CH01330A IN 1330CH2015 A IN1330CH2015 A IN 1330CH2015A IN 2015CH01330 A IN2015CH01330 A IN 2015CH01330A
Authority
IN
India
Prior art keywords
azilsartan
preparation
oxadiazol
benzimidazole
biphenyl
Prior art date
Application number
Other languages
English (en)
Inventor
Vijaya Kumar Kotagiri
Raghavendra Rao Yenumula
Mohan Bandari
Suryadevara Muralikrishna
Original Assignee
Smilax Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of IN2015CH01330A publication Critical patent/IN2015CH01330A/en
Application filed by Smilax Lab Ltd filed Critical Smilax Lab Ltd
Priority to IN1330CH2015 priority Critical patent/IN2015CH01330A/en
Priority to PCT/IB2016/051470 priority patent/WO2016147120A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN1330CH2015 2015-03-18 2016-03-16 IN2015CH01330A (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1330CH2015 IN2015CH01330A (zh) 2015-03-18 2016-03-16
PCT/IB2016/051470 WO2016147120A1 (en) 2015-03-18 2016-03-16 An improved process for the preparation of substantially pure azilsartan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1330CH2015 IN2015CH01330A (zh) 2015-03-18 2016-03-16

Publications (1)

Publication Number Publication Date
IN2015CH01330A true IN2015CH01330A (zh) 2015-08-14

Family

ID=54395758

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1330CH2015 IN2015CH01330A (zh) 2015-03-18 2016-03-16

Country Status (2)

Country Link
IN (1) IN2015CH01330A (zh)
WO (1) WO2016147120A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6856365B2 (ja) * 2016-11-30 2021-04-07 株式会社トクヤマ アジルサルタンの製造方法
CN109071519A (zh) * 2016-01-28 2018-12-21 株式会社德山 阿齐沙坦及其制造方法
CN106841415B (zh) * 2016-12-20 2019-03-22 合肥拓锐生物科技有限公司 一种阿齐沙坦原料及其制剂中有关物质的分析方法
CN108912109A (zh) * 2018-08-17 2018-11-30 珠海润都制药股份有限公司 一种高纯度、小粒径及低溶剂残留的阿齐沙坦原料药及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ306650B6 (cs) * 2011-03-04 2017-04-19 Zentiva, K.S. Způsob výroby 2-ethoxy-1-((2´-((hydroxyamino)iminomethyl)bifenyl-4-yl)methyl)-1H-benzo[d]imidazol-7-karboxylové kyseliny a jejích esterů, klíčových intermediátů syntézy azilsartanu
CN103242305B (zh) * 2013-05-11 2018-02-27 迪沙药业集团有限公司 一种阿齐沙坦的制备方法

Also Published As

Publication number Publication date
WO2016147120A1 (en) 2016-09-22

Similar Documents

Publication Publication Date Title
WO2012107814A8 (en) An improved process for the preparation of azilsartan medoxomil
TN2017000204A1 (en) Triazolopyrimidine compounds and uses thereof
MY176210A (en) Process for the preparation of n-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine
IN2015CH01330A (zh)
SA113340696B1 (ar) تصنيع 2-(5-برومو-4-(4-سيكلو بروبيل نافثالين-1-يل)-4 h-1، 2، 4- ترازول-3- يل ثيو) حمض أسيتيك
NZ601121A (en) 5-alkynyl-pyrimidines
MX2018001204A (es) Metodo para preparar derivados de acido 3-(2-anilino-1-ciclohexil- 1h-bencimidazol-5-il)propanoico sustituido.
PH12019502093A1 (en) Novel ester compounds, method for the production thereof and use thereof
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
MX362371B (es) Proceso para preparar 2-metoximetil-1,4-bencenodiamina y sales de esta.
MX2019011261A (es) Compuestos de isoxazol carboxamida y sus usos.
WO2012148148A3 (en) Novel zinc azide complex and a process for preparing tetrazole derivatives using the same
PH12017501404A1 (en) Diaza-benzofluoranthrene compounds
WO2014087208A3 (en) A process of preparing alcaftadine
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
SG10201901578UA (en) Processes for the preparation of pyrimidinylcyclopentane compounds
PH12014502747A1 (en) Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 - sulfonamide
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
PH12015502652A1 (en) Methods for treatment of inflammatory conditions using s-[4-(3-fluoro-3-methylbutyryloxy) but-2-ynyl] 6alpha, 9alpha-difluoro-17alpha-(furan-2-yl) carbonyloxy-11beta -hydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta -carbothioate.
WO2014178064A3 (en) "an improved process for the preparation of fluvoxamine maleate"
UA104102C2 (en) α-CRYSTALLINE FORM OF CARBABENZPYRIDE
WO2016059646A3 (en) Improved process for the preparation of 4- [6-amino-5-bromo-2- [(4-cvanophenyl) aminol]-4-pvrimidinvl]oxv]-3.5-dimethvlbenzonitrile
MX2012013362A (es) Una composicion farmaceutica de liberacion controlada de losartan.